Business Description
Ascendis Health Ltd
ISIN : ZAE000185005
Compare
Compare
Traded in other countries / regions
ASC.South Africa IPO Date
2013-11-22Description
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is theĀ contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.06 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -6.08 | |||||
| Beneish M-Score | -1.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.8 | |||||
| 3-Year EBITDA Growth Rate | 45.1 | |||||
| 3-Year EPS without NRI Growth Rate | 38.5 | |||||
| 3-Year Book Growth Rate | -30.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.19 | |||||
| 9-Day RSI | 49.68 | |||||
| 14-Day RSI | 50.34 | |||||
| 6-1 Month Momentum % | 14.29 | |||||
| 12-1 Month Momentum % | 29.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.97 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.27 | |||||
| Days Inventory | 153.87 | |||||
| Days Sales Outstanding | 63.12 | |||||
| Days Payable | 106.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9 | |||||
| Shareholder Yield % | 84.76 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.37 | |||||
| Operating Margin % | -12.86 | |||||
| Net Margin % | 4.91 | |||||
| FCF Margin % | -11.48 | |||||
| ROE % | 13.63 | |||||
| ROA % | 5.59 | |||||
| ROIC % | -21.4 | |||||
| ROC (Joel Greenblatt) % | -41.97 | |||||
| ROCE % | -35.3 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.37 | |||||
| Price-to-Owner-Earnings | 15.69 | |||||
| PS Ratio | 0.32 | |||||
| PB Ratio | 0.88 | |||||
| Price-to-Tangible-Book | 0.95 | |||||
| EV-to-EBIT | -1.87 | |||||
| EV-to-EBITDA | -1.87 | |||||
| EV-to-Revenue | 0.29 | |||||
| EV-to-FCF | -2.54 | |||||
| Price-to-Projected-FCF | 0.31 | |||||
| Price-to-Median-PS-Value | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 1.48 | |||||
| Earnings Yield (Greenblatt) % | -53.48 | |||||
| FCF Yield % | -35.19 | |||||
| Forward Rate of Return (Yacktman) % | -1.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Ascendis Health Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R) | 1,535.437 | ||
| EPS (TTM) (R) | 0.124 | ||
| Beta | 0.26 | ||
| Volatility % | 16.79 | ||
| 14-Day RSI | 50.34 | ||
| 14-Day ATR (R) | 0.020011 | ||
| 20-Day SMA (R) | 0.799 | ||
| 12-1 Month Momentum % | 29.03 | ||
| 52-Week Range (R) | 0.59 - 0.83 | ||
| Shares Outstanding (Mil) | 626.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ascendis Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ascendis Health Ltd Stock Events
| Event | Date | Price(R) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ascendis Health Ltd Frequently Asked Questions
What is Ascendis Health Ltd(JSE:ASC)'s stock price today?
The current price of JSE:ASC is R0.80. The 52 week high of JSE:ASC is R0.83 and 52 week low is R0.59.
When is next earnings date of Ascendis Health Ltd(JSE:ASC)?
The next earnings date of Ascendis Health Ltd(JSE:ASC) is .
Does Ascendis Health Ltd(JSE:ASC) pay dividends? If so, how much?
Ascendis Health Ltd(JSE:ASC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers